These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 3528827)

  • 1. Effects of norharman on the mutagenicity of chlorophenylhydroxylamine and its metabolism with rat liver S9.
    Suzuki J; Kobayashi Y; Monden S; Suzuki S
    Mutat Res; 1986 Sep; 162(2):165-72. PubMed ID: 3528827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dependence on Salmonella typhimurium enzymes of mutagenicities of nitrobenzene and its derivatives in the presence of rat-liver S9 and norharman.
    Suzuki J; Takahashi N; Kobayashi Y; Miyamae R; Ohsawa M; Suzuki S
    Mutat Res; 1987 Jun; 178(2):187-93. PubMed ID: 3295532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structures of mutagens produced by the co-mutagen norharman with o- and m-toluidine isomers.
    Hada N; Totsuka Y; Enya T; Tsurumaki K; Nakazawa M; Kawahara N; Murakami Y; Yokoyama Y; Sugimura T; Wakabayashi K
    Mutat Res; 2001 Jun; 493(1-2):115-26. PubMed ID: 11516721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenic activation of carcinogenic N-nitrosopropylamines by rat liver: evidence for a cytochrome P-450 dependent reaction.
    Mori Y; Yamazaki H; Toyoshi K; Makino T; Obara T; Yokose Y; Konishi Y
    Carcinogenesis; 1985 Mar; 6(3):415-20. PubMed ID: 3884171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenicities of mono-nitrobenzene derivatives in the presence of norharman.
    Suzuki J; Koyama T; Suzuki S
    Mutat Res; 1983 May; 120(2-3):105-10. PubMed ID: 6341826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of S9 mix from rat oesophagus, salivary gland, and liver on the mutagenicity of the rat oesophageal carcinogen N-nitroso-N-methylaniline in the Salmonella typhimurium assay.
    Anderson D; Blowers SD; Craddock VM
    Mutat Res; 1985; 142(1-2):13-8. PubMed ID: 3883137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo formation of aminophenylnorharman from norharman and aniline.
    Totsuka Y; Kataoka H; Takamura-Enya T; Sugimura T; Wakabayashi K
    Mutat Res; 2002 Sep; 506-507():49-54. PubMed ID: 12351144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of DNA adducts by the co-mutagen norharman with aromatic amines.
    Mori M; Totsuka Y; Fukutome K; Yoshida T; Sugimura T; Wakabayashi K
    Carcinogenesis; 1996 Jul; 17(7):1499-503. PubMed ID: 8706255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural determination of a mutagenic aminophenylnorharman produced by the co-mutagen norharman with aniline.
    Totsuka Y; Hada N; Matsumoto K; Kawahara N; Murakami Y; Yokoyama Y; Sugimura T; Wakabayashi K
    Carcinogenesis; 1998 Nov; 19(11):1995-2000. PubMed ID: 9855015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Test-condition-dependent influence of harman and nonharman on benzo[a]pyrene mutagenesis in Salmonella.
    Riebe M; Westphal K; Keller H
    Mutat Res; 1982 Apr; 104(1-3):9-15. PubMed ID: 7043258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difference in liver homogenates from Donryu, Fischer, Sprague-Dawley and Wistar strains of rat in the drug-metabolizing enzyme assay and the Salmonella/hepatic S9 activation test.
    Yoshikawa K; Nohmi T; Miyata R; Ishidate M; Ozawa N; Isobe M; Watabe T; Kada T; Kawachi T
    Mutat Res; 1982 Oct; 96(2-3):167-86. PubMed ID: 6755239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative activation of 3,3'-dichlorobenzidine and related benzidines to mutagens in the Salmonella typhimurium assay by hepatic S9 and microsomes from rats pretreated with different inducers of cytochrome P-450.
    Iba MM
    Mutat Res; 1987 Oct; 182(5):231-41. PubMed ID: 3309638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlorination of harman and norharman with sodium hypochlorite and co-mutagenicity of the chlorinated products.
    Nakano K; Suyama K; Fukazawa H; Uchida M; Wakabayashi K; Shiozawa T; Terao Y
    Mutat Res; 2000 Oct; 470(2):141-6. PubMed ID: 11027968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comutagenic effect of norharman with aminopyridine derivatives.
    Wakabayashi K; Yahagi T; Nagao M; Sugimura T
    Mutat Res; 1982 Oct; 105(4):205-10. PubMed ID: 7133029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of pre-incubation period and norharman on the mutagenic potency of 4-dimethylaminoazobenzene and 3'-methyl-4-dimethylaminoazobenzene in S. typhimurium.
    Lefevre PA; Ashby J
    Carcinogenesis; 1981; 2(9):927-31. PubMed ID: 6794927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some factors determining the concentration of liver proteins for optimal mutagenicity of chemicals in the Salmonella/microsome assay.
    Malaveille C; Kuroki T; Brun G; Hautefeuille A; Camus AM; Bartsch H
    Mutat Res; 1979 Dec; 63(2):245-58. PubMed ID: 392308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic activation of 2-amino-9H-pyrido[2,3-b]indole by rat-liver microsomes.
    Niwa T; Yamazoe Y; Kato R
    Mutat Res; 1982 Aug; 95(2-3):159-70. PubMed ID: 6750381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The differential mutagenicity of isoniazid in fluctuation assays and Salmonella plate tests.
    Gatehouse D; Wedd DJ
    Carcinogenesis; 1984 Mar; 5(3):391-7. PubMed ID: 6368032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of norharman on the metabolism of benzo[alpha]pyrene by rat-liver microsomes in vitro in relation to its enhancement of the mutagenicity of benzo[alpha]pyrene.
    Fujino T; Fujiki H; Nagao M; Yahagi T; Seino Y; Sugimura T
    Mutat Res; 1978 Nov; 58(2-3):151-8. PubMed ID: 370567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenicity studies on coffee. The influence of different factors on the mutagenic activity in the Salmonella/mammalian microsome assay.
    Friederich U; Hann D; Albertini S; Schlatter C; Würgler FE
    Mutat Res; 1985; 156(1-2):39-52. PubMed ID: 3889626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.